SCHEMBL5525868

SCHEMBL5525868

CCCc1c(C)cc(C(=O)NC2(CC(=O)O)CCC(C)(C)CC2)c(=O)n1CCOC

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 11/20 0.48
CNR1 P21554 6/20 0.39
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KDM4E B2RXH2 1/20 0.32
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
HSD17B10 Q99714 1/20 0.31
ALDH1A1 P00352 1/20 0.30
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30
HTT P42858 1/20 0.30
PARG Q86W56 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14679046 0.93 CNR2 (0.54) CNR2CNR1NPC1RAB9ALMNA
SCHEMBL11922999 0.91 CNR2 (0.46) CNR2CNR1NPC1RAB9ALMNA
SCHEMBL14679045 0.90 CNR2 (0.47) CNR2CNR1NPC1RAB9ALMNA
SCHEMBL14679047 0.87 CNR2 (0.61) CNR2CNR1
SCHEMBL5517384 0.83 CNR2 (0.51) CNR2CNR1NPC1RAB9ALMNA
SCHEMBL5517380 0.81 CNR2 (0.45) CNR2CNR1
SCHEMBL5523176 0.77 CNR2 (0.58) CNR2CNR1
SCHEMBL11920673 0.76 CNR2 (0.49) CNR2CNR1SMN1; SMN2KDM4EHSD17B10
SCHEMBL5517123 0.74 CNR2 (0.59) CNR2CNR1
SCHEMBL5521498 0.73 CNR2 (0.62) CNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed